10 Posts Not To Miss From SOHO2024!

The twelfth annual meeting of the Society of Hematologic Oncology (SOHO 2024) was held from September 4-7, 2024 at the George R. Brown Convention Center in Houston, Texas.

Our team at OncoDaily has selected a few highlights from the SOHO2024 that you should not miss!

Jayastu Senapati 

“Happy to get the Second Place Poster Session Award at SOHO2024 on Venetoclax added to HyperCVAD-Nelarabine, Pegaspargase In T-cell Acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL), Phase 2 study.”

Lisa Palacios

“Ran into some familiar MD Anderson Cancer Center faces at SOHO2024 on Day 1. Society of Hematologic Oncology President G Garcia-Manero with M. Silverstein, Navel Daver and Tapan Kadia.”

Jeff Lancet 

“Moffitt MDS world expert Rami Komrokji moderating MDS session at SOHO2024, novel targeted therapies effectively reducing transfusion dependence in MDS – including trials led and run at Moffitt!”

Parisa Aijaz

“Here for a day full of learning and meeting leaders of the field.

SOHO2024 happy with how our posters turned out!

It was so lovely finally meeting you in person Nausheen Ahmed, USMIRC News.”

Mamtha Balla

“I am incredibly grateful for the approval of my team research to be presented at SOHO2024. I am thrilled about the opportunity to showcase it at a poster presentation! I appreciate this chance!

Society of Hematologic Oncology, MD Anderson Cancer Center, Heme-Onc Fellowship Mentorship Empowerment, Heme-Onc Fellows Network, HemeOnc Today. Thanks Hagop Kantarjian, Guillermo Garcio Manero.”

Anand Patel

“Had a great time at Society of Hematologic Oncology SOHO2024 presenting about challenging MPN scenarios!

I also learned a ton about anemia-directed therapies in myelofibrosis from Stephen Oh and JAK2m clonal hematopoiesis from Lachelle Dawn!”

Kelly Meza

“What an incredible start at SOHO24!

Such a valuable chance to engage with exceptional thought leaders and peers from around the globe, I was honored to share my research on Adult T-cell leukemia/lymphoma (ATLL), myelofibrosis and Hemophagocytic lymphohistiocytosis (HLH) at MD Anderson Cancer Center.

Concluded with a stimulating discussion led by Christopher Flowers.”

Bilal Abid

“Talk of the day: ‘Early versus late Chimeric antigen receptor (CAR)-T in Myeloma.’ No consensus reached but both sides up a notch with life qoutes, sports and music references! Just because you can do something doesn’t mean you should do it”

Nitin Jain

“John Seymour giving Michael Keating plenary award lecture at SOHO24.

First patient ever treated with venetoclax previously called ABT-199 was in June 2011 in Australia with Seymour.

Amazing how this drug has changed the practice of leukemia care, especially Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML).”

Kim Aldecoa

“One of the best aspects of conferences: the chance to meet friends and like-minded individuals who share the same passion.”

For more details on SOHO2024, click here.